Results 21 to 30 of about 147,528 (279)
Cutaneous T-cell Lymphoma [PDF]
Cancer Control, 1998 Background: Cutaneous T-cell lymphoma (CTCL) represents a spectrum of diseases composed of malignant helper T lymphocytes. An accurate diagnosis of early CTCL is difficult because of the varied clinical and histologic expressions of the disease. Methods: The authors review the epidemiology, possible risk factors, clinical manifestations, diagnostic ...
Jane L. Messina +5 more
openaire +3 more sources
Therapeutic Efficacy of Etretinate on Cutaneous-type Adult T-cell Leukemia-Lymphoma
Acta Dermato-Venereologica, 2019 Cutaneous-type adult T-cell leukemia-lymphoma is treated with antiviral or skin-directed therapy. Medications that are used to treat skin lesions of cutaneous T-cell lymphomas are also used for the cutaneous-type adult T-cell leukemia-lymphoma ...
Kentaro Yonekura +5 more
doaj +1 more source
Cutaneous anaplastic large T-cell lymphoma in a cat - case report [PDF]
Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2023 Lymphoma is the most common lymphoproliferative disorder in cats. However, cutaneous lymphomas are uncommon in this species and can be classified as epitheliotropic or non-epitheliotropic.
R.D. Mazaro +5 more
doaj +1 more source
Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma.
Blood, 2019 It has been proposed that CD4 T cell responses to Staphylococcus aureus (SA) can inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T cell lymphoma (CTCL).
L. Lindahl +30 more
semanticscholar +1 more source
Cutaneous T-cell lymphoma developing in surgical scars post cardiac surgery: A case study
SAGE Open Medical Case Reports, 2023 Cutaneous T-cell lymphomas are a class of non-Hodgkin lymphomas characterized by the infiltration of malignant T cells into the skin. Their precise pathogenesis remains incompletely understood, but persistent and specific antigen stimulation of skin ...
Sarah J Touyz +8 more
doaj +1 more source
British Journal of Haematology, 2018 miR‐155, a microRNA associated with poor prognosis in lymphoma and leukaemia, has been implicated in the progression of mycosis fungoides (MF), the most common form of cutaneous T‐cell lymphoma (CTCL).
A. Seto +6 more
semanticscholar +1 more source
Distribution and clinical features of lymphomas involving skin in Taiwan
Kaohsiung Journal of Medical Sciences, 2023 A wide variety of primary and secondary lymphoma types involves the skin. However, reports with comparisons between both groups are limited in Taiwan.
Cheng‐Lin Wu +7 more
doaj +1 more source
Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
OncoTargets and Therapy, 2019 Cutaneous T-cell lymphoma (CTCL) poses unique treatment challenges, given its range of presentations and numerous systemic therapy options. These options often lack comparative evidence or are characterized by low response rates and short remission ...
T. Ollila, I. Sahin, A. Olszewski
semanticscholar +1 more source
Romidepsin for Cutaneous T-cell Lymphoma [PDF]
Clinical Cancer Research, 2012 Abstract Cutaneous T-cell lymphomas (CTCL) are relatively rare lymphomas with an annual incidence of approximately 0.2 to 0.8/100,000 and comprise a variety of clinical entities; mycosis fungoides or its leukemic variant Sezary syndrome account for the majority of cases.
H. Miles Prince +2 more
openaire +3 more sources
Skin Directed Therapy in Cutaneous T-Cell Lymphoma
Frontiers in Oncology, 2019 Skin directed therapies (SDTs) serve important roles in the treatment of early stage cutaneous T-cell lymphoma (CTCL)/mycosis fungoides (MF), as well as managing symptoms and improving quality of life of all stages.
E. Tarabadkar, M. Shinohara
semanticscholar +1 more source